ScienceChina’s pharma revolution: from follower to global player
China approved a novel drug for a brain receptor linked to type 1 narcolepsy in July 2026 and made it available domestically first. The article says regulatory reforms, a growing drug pipeline, faster approvals and more international trials are turning China from a market for imported innovations into a major hub for discovering, testing and developing medicines.
C
CGTN★★★☆☆2026-09-09 07:37Original
China’s pharma revolution: from follower to global player
Science